Outset Medical (OM) Cash from Financing Activities (2019 - 2026)
Outset Medical's (OM) quarterly Cash from Financing Activities came in at -$88000.0 in Q2 2026, up 77.08% year-over-year from -$49694.1 in Q2 2025, and down 117.56% quarter-over-quarter from $501000.0 in Q1 2026.
Powered by 
Analysis
Outset Medical (OM) Cash from Financing Activities (2019 - 2026) Analysis & Trends
Outset Medical (OM) has reported Cash from Financing Activities for 8 consecutive years, with -$88000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Financing Activities rose 77.08% year-over-year to -$88000.0 in Q2 2026; TTM through Jun 2026 was $644000.0, a 98.82% decrease from a year earlier, with the FY2025 full-year figure at $55.5 million, down 18.22% from the prior year.
- Cash from Financing Activities was -$88000.0 for Q2 2026 at Outset Medical, down from $501000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $68.6 million in Q1 2024 and troughed at -$938000.0 in Q4 2024.
- A 5-year average of $14.1 million and a median of $1.0 million in 2023 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities jumped 6923.55% in 2022 and sank 598.7% in 2025, its largest moves.
- Over 5 years, Cash from Financing Activities stood at $65.6 million in 2022, then plunged by 49.35% to $33.2 million in 2023, then sank by 102.82% to -$938000.0 in 2024, then surged by 124.63% to $231000.0 in 2025, then slumped by 138.1% to -$88000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$88000.0 (Q2 2026), $501000.0 (Q1 2026), and $231000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.05 Bn | 174.44 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 127.97 Bn | 122.75 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 117.27 Bn | 108.45 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 103.98 Bn | 100.50 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 63.03 Bn | 62.49 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 32.93 Bn | 31.47 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.26 Bn | 30.31 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Outset Medical | 59.95 Mn | -203.24 Mn | 13.28 Mn | -88,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -88,000.00 |
| Mar 31, 2026 | 501,000.00 |
| Sep 30, 2025 | 231,000.00 |
| Jun 30, 2025 | -384,000.00 |
| Mar 31, 2025 | 55.66 Mn |
| Dec 31, 2024 | -938,000.00 |
| Sep 30, 2024 | 121,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | 68.61 Mn |
| Dec 31, 2023 | 33.23 Mn |
| Sep 30, 2023 | 4.10 Mn |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 5.28 Mn |
| Dec 31, 2022 | 65.60 Mn |
| Sep 30, 2022 | 2.53 Mn |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 3.72 Mn |
| Dec 31, 2021 | 934,000.00 |
| Sep 30, 2021 | 6.19 Mn |
| Jun 30, 2021 | 150.81 Mn |